1 김승조, "한국형 자궁경부 촬영진(New Cervicography), 세포검사 그리고 HPV-DNA 검사를 이용한 새로운 자궁경부암 검진 모델(Model) 개발" 대한산부인과학회 44 (44): 911-937, 2001
2 김용범, "한국여성의 자궁경부암에서 인유두종바이러스의 감염 양상" 대한산부인과학회 46 (46): 789-794, 2003
3 이제훈, "자궁경부암 조직을 이용한유전자 칩 인유두종바이러스 검사" 대한산부인과학회 49 (49): 858-865, 2006
4 위정하, "자궁 경부 전암 병변 및 자궁 경부암 환자에서의 HPV 감염 양상 및다중감염의 분포" 대한부인종양콜포스코피학회 17 (17): 39-46, 2006
5 Pollack AE, "WHO/UNFPA Working Group on Sexual and Reproductive Health and HPV Vaccines. Ensuring access to HPV vaccines through integrated services: a reproductive health perspective" 85 : 57-63, 2007
6 Shin HR, "Trends in cervical cancer mortality in Korea 1993-2002: corrected mortality using national death certification data and national cancer incidence data" 122 : 393-397, 2008
7 Lacey CJ, "Therapy for genital human papillomavirus-related disease" 32 (32): S82-S90, 2005
8 The Ministry of Health and Welfare, "The third Korean national health and nutrition examination survey" Korea Center for Disease Control 2005
9 The Ministry of Health and Welfare, "The second Korean national health and nutrition examination survey" Korea Center for Disease Control and Prevention 2001
10 The Ministry of Health and Welfare, "The first Korean national health and nutrition examination survey" Korea Center for Disease Control 1998
1 김승조, "한국형 자궁경부 촬영진(New Cervicography), 세포검사 그리고 HPV-DNA 검사를 이용한 새로운 자궁경부암 검진 모델(Model) 개발" 대한산부인과학회 44 (44): 911-937, 2001
2 김용범, "한국여성의 자궁경부암에서 인유두종바이러스의 감염 양상" 대한산부인과학회 46 (46): 789-794, 2003
3 이제훈, "자궁경부암 조직을 이용한유전자 칩 인유두종바이러스 검사" 대한산부인과학회 49 (49): 858-865, 2006
4 위정하, "자궁 경부 전암 병변 및 자궁 경부암 환자에서의 HPV 감염 양상 및다중감염의 분포" 대한부인종양콜포스코피학회 17 (17): 39-46, 2006
5 Pollack AE, "WHO/UNFPA Working Group on Sexual and Reproductive Health and HPV Vaccines. Ensuring access to HPV vaccines through integrated services: a reproductive health perspective" 85 : 57-63, 2007
6 Shin HR, "Trends in cervical cancer mortality in Korea 1993-2002: corrected mortality using national death certification data and national cancer incidence data" 122 : 393-397, 2008
7 Lacey CJ, "Therapy for genital human papillomavirus-related disease" 32 (32): S82-S90, 2005
8 The Ministry of Health and Welfare, "The third Korean national health and nutrition examination survey" Korea Center for Disease Control 2005
9 The Ministry of Health and Welfare, "The second Korean national health and nutrition examination survey" Korea Center for Disease Control and Prevention 2001
10 The Ministry of Health and Welfare, "The first Korean national health and nutrition examination survey" Korea Center for Disease Control 1998
11 Behbakht K, "Social and cultural barriers to Papanicolaou test screening in an urban population" 104 : 355-1361, 2004
12 Korean Center for Disease Control and Prevention, "Second online survey for the health behavioral factors among adolescents in Korea in 2006" Korea Center for Disease Control and Prevention 2006
13 Schneider A, "Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy" 89 : 529-534, 2000
14 Cooper CP, "Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program" 14 : 670-678, 2005
15 Miller BA, "Racial/ethnic patterns of cancer in the United States 1988-1992" National Cancer Institute 1996
16 Lowy DR, "Prophylactic human papillomavirus vaccines" 116 : 1167-1173, 2006
17 Joo WD, "Prevalence of human papillomavirus infection in Korean women: risks of abnormal Pap smear and cervical neoplasia" 15 : 309-316, 2004
18 Oh JK, "Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea" 18 : 56-61, 2009
19 An HJ, "Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a populationbased study" 18 : 528-534, 2005
20 Shin HR, "Prevalence of human papilloma virus infection in women in Busan, South Korea" 103 : 413-421, 2003
21 Shin HR, "Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea" 190 : 468-476, 2004
22 Hai-Rim Shin, "National Cancer Incidence for the Year 2002 in Korea" 대한암학회 39 (39): 139-149, 2007
23 Bernstein SJ, "Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a meta-analysis of prospective studies comparing cytologic diagnosis and sample adequacy" 185 : 308-317, 2001
24 Shin JH, "Hybrid capture system HPV DNA test as a screening tool of cervical cancer" 12 : 31-38, 2001
25 Lee HS, "Human papillomavirus genotyping using HPV DNA chip analysis in Korean women" 17 : 497-501, 2007
26 Park TC, "Human papillomavirus genotyping by the DNA chip in the cervical neoplasia" 23 : 119-125, 2004
27 Bae, Jeong-Hoon, "Human Papillomavirus (HPV) Type Distribution in Korean Women: A Meta-Analysis" 한국미생물·생명공학회 18 (18): 788-794, 2008
28 Womack SD, "HPV-based cervical cancer screening in a population at high risk for HIV infection" 85 : 206-210, 2000
29 Paavonen J, "HPV PATRICIA study group. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomized controlled trial" 369 : 2161-2170, 2007
30 Wright Jr TC, "HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer" 283 : 81-86, 2000
31 Schiffman M, "HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica" 283 : 87-93, 2000
32 Cho NH, "Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis" 188 : 56-62, 2003
33 Ault KA, "Future II Study Group. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials" 369 : 1861-1868, 2007
34 Garland SM, "Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators: quadrivalent vaccine against human papillomavirus to prevent anogenital diseases" 356 : 1928-1943, 2007
35 Freeman HP, "Excess cervical cancer mortality: a marker for low access to health care in poor communities" National Cancer Institute 2005
36 Munoz N, "Epidemiologic classification of human papillomavirus types associated with cervical cancer" 348 : 518-527, 2003
37 Hwang T, "Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women" 14 : 593-599, 1999
38 Hwang TS, "Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray" 90 : 51-56, 2003
39 An HJ, "Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method" 97 : 1672-1680, 2003
40 De Villiers EM, "Classification of papillomaviruses" 324 : 17-27, 2004
41 Park HK, "Cervical intraepithelial neoplasia and cervical cancer" 14 : 123-132, 2003
42 Chung HH, "Cervical cancer incidence and survival in Korea: 1993-2002" 16 : 1833-1838, 2002
43 Curado MP, "Cancer incidence in five continents. Volume IX" IARC 2007
44 Parkin DM, "Cancer incidence in five continents, vol. VIII" IARC 2002
45 Kyu-Won Jung, "Cancer Survival in Korea 1993-2002: A Population-Based Study" 대한의학회 22 (22): 5-10, 2007
46 Blumenthal PD, "Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear" 72 : 47-53, 2001
47 Nanda K, "Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review" 132 : 810-819, 2000
48 Koo HW, "A case-control study on risk factors of uterine cervix cancer in Korea" 29 : 159-172, 1996